EXACT SCIENCES CORP (EXAS) Current Deferred Revenue (2010 - 2013)
Exact Sciences (EXAS) posted quarterly Current Deferred Revenue of $294000.0 for Q4 2013, down 92.9% year-over-year from $4.1 million in Q4 2012, and down 77.89% quarter-over-quarter from $1.3 million in Q3 2013.
EXACT SCIENCES CORP (EXAS) Current Deferred Revenue (2010 - 2013) Analysis & Trends
Exact Sciences (EXAS) has reported Current Deferred Revenue for 4 consecutive years, with $294000.0 the latest figure, recorded in Q4 2013.
- In Q4 2013, Current Deferred Revenue fell 92.9% year-over-year to $294000.0; the TTM figure through Dec 2013 stood at $294000.0 (down 92.9% YoY), while the FY2013 annual figure was $294000.0, down 92.9% from the prior year.
- Current Deferred Revenue fell to $294000.0 in Q4 2013 per EXAS's latest filing, from $1.3 million in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $4.1 million in Q4 2010 and bottomed at $294000.0 in Q4 2013.
- Historically, Current Deferred Revenue has averaged $3.4 million across 4 years, with a median of $4.1 million in 2010.
- Annual changes were most pronounced in 2011 — Current Deferred Revenue changed 0.0% — and 2013, when it slumped 92.9%.
- Exact Sciences' Current Deferred Revenue stood at $4.1 million in 2010, then changed by 0.0% to $4.1 million in 2011, then changed by 0.0% to $4.1 million in 2012, then plunged by 92.9% to $294000.0 in 2013.
- Business Quant data shows EXAS's Current Deferred Revenue at $294000.0 in Q4 2013, $1.3 million in Q3 2013, and $2.4 million in Q2 2013.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2013 | 294,000.00 |
| Sep 30, 2013 | 1.33 Mn |
| Jun 30, 2013 | 2.37 Mn |
| Mar 31, 2013 | 3.40 Mn |
| Dec 31, 2012 | 4.14 Mn |
| Sep 30, 2012 | 4.14 Mn |
| Jun 30, 2012 | 4.14 Mn |
| Mar 31, 2012 | 4.14 Mn |
| Dec 31, 2011 | 4.14 Mn |
| Sep 30, 2011 | 4.14 Mn |
| Jun 30, 2011 | 4.14 Mn |
| Dec 31, 2010 | 4.14 Mn |